Related references
Note: Only part of the references are listed.Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man
Eleanor Barnes et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Design of therapeutic vaccines: hepatitis B as an example
Sarah Kutscher et al.
MICROBIAL BIOTECHNOLOGY (2012)
Vaccination for hepatitis C virus: closing in on an evasive target
John Halliday et al.
EXPERT REVIEW OF VACCINES (2011)
Early Changes in Natural Killer Cell Function Indicate Virologic Response to Interferon Therapy for Hepatitis C
Golo Ahlenstiel et al.
GASTROENTEROLOGY (2011)
A Poxvirus Vaccine Is Safe, Induces T-Cell Responses, and Decreases Viral Load in Patients With Chronic Hepatitis C
Francois Habersetzer et al.
GASTROENTEROLOGY (2011)
A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease
Michael L. Washburn et al.
GASTROENTEROLOGY (2011)
Interferon lambdas: the next cytokine storm
Christabel Kelly et al.
GUT (2011)
Genetic Variation in Interleukin 28B with Respect to Vertical Transmission of Hepatitis C Virus and Spontaneous Clearance in HCV-Infected Children
Angeles Ruiz-Extremera et al.
HEPATOLOGY (2011)
Both Innate and Adaptive Immunity Mediate Protective Immunity Against Hepatitis C Virus Infection in Chimpanzees
Heidi Barth et al.
HEPATOLOGY (2011)
Natural Killer Inhibitory Receptor Expression Associated with Treatment Failure and Interleukin-28B Genotype in Patients with Chronic Hepatitis C
Lucy Golden-Mason et al.
HEPATOLOGY (2011)
Clearance of Genotype 1b Hepatitis C Virus in Chimpanzees in the Presence of Vaccine-Induced E1-Neutralizing Antibodies
Babs E. Verstrepen et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Tupaia CD81, SR-BI, Claudin-1, and Occludin Support Hepatitis C Virus Infection
Yimin Tong et al.
JOURNAL OF VIROLOGY (2011)
A genetically humanized mouse model for hepatitis C virus infection
Marcus Dorner et al.
NATURE (2011)
Decreased IP-10 and elevated TGF beta 1 levels are associated with viral clearance following therapy in patients with hepatitis C virus
Silvia Lee et al.
DISEASE MARKERS (2010)
Interferon-α-Induced TRAIL on Natural Killer Cells Is Associated With Control of Hepatitis C Virus Infection
Kerstin A. Stegmann et al.
GASTROENTEROLOGY (2010)
Ribavirin Improves Early Responses to Peginterferon Through Improved Interferon Signaling
Jordan J. Feld et al.
GASTROENTEROLOGY (2010)
Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study
Andri Rauch et al.
GASTROENTEROLOGY (2010)
Spontaneous Control of Primary Hepatitis C Virus Infection and Immunity Against Persistent Reinfection
William O. Osburn et al.
GASTROENTEROLOGY (2010)
Selection-Driven Immune Escape Is Not a Significant Factor in the Failure of CD4 T Cell Responses in Persistent Hepatitis C Virus Infection
Michael J. Fuller et al.
HEPATOLOGY (2010)
Specific Human Leukocyte Antigen Class I and II Alleles Associated with Hepatitis C Virus Viremia
Mark H. Kuniholm et al.
HEPATOLOGY (2010)
Increased Natural Killer Cell Cytotoxicity and NKp30 Expression Protects Against Hepatitis C Virus Infection in High-Risk Individuals and Inhibits Replication In Vitro
Lucy Golden-Mason et al.
HEPATOLOGY (2010)
Animal models for hepatitis C and related liver disease
Kazuhiko Koike et al.
HEPATOLOGY RESEARCH (2010)
Immunization with a DNA vaccine candidate in chronic hepatitis C patients is safe, well tolerated and does not impair immune response induction after anti-hepatitis B vaccination
Marlen Castellanos et al.
JOURNAL OF GENE MEDICINE (2010)
A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals
Eric J. Gowans et al.
JOURNAL OF HEPATOLOGY (2010)
Characterization of Antibodies Induced by Vaccination with Hepatitis C Virus Envelope Glycoproteins
Ranjit Ray et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Analyses of amino acid sequences in hypervariable region-1 of hepatitis C virus (HCV) in sera from chimpanzees infected three times with the same HCV strain
M. Sugitani et al.
JOURNAL OF MEDICAL PRIMATOLOGY (2010)
Clearance of hepatitis C in chimpanzees is associated with intrahepatic T-cell perforin expression during the late acute phase
H. Watanabe et al.
JOURNAL OF VIRAL HEPATITIS (2010)
Pathogenesis of Hepatitis C Virus Infection in Tupaia belangeri
Yutaka Amako et al.
JOURNAL OF VIROLOGY (2010)
Pathogenesis of Hepatitis E Virus and Hepatitis C Virus in Chimpanzees: Similarities and Differences
Claro Yu et al.
JOURNAL OF VIROLOGY (2010)
Hepatitis C virus with a naturally occurring single amino-acid substitution in the E2 envelope protein escapes neutralization by naturally-induced and vaccine-induced antibodies
Hongying Duan et al.
VACCINE (2010)
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults
Sharon E. Frey et al.
VACCINE (2010)
Characterization of natural killer cells in tamarins: a technical basis for studies of innate immunity
Tomoyuki Yoshida et al.
FRONTIERS IN MICROBIOLOGY (2010)
Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles
Shigeru Yutani et al.
CANCER SCIENCE (2009)
Early viraemia clearance during antiviral therapy of chronic hepatitis C improves dendritic cell functions
Ioannis Pachiadakis et al.
CLINICAL IMMUNOLOGY (2009)
DNA vaccine therapy for chronic hepatitis C virus (HCV) infection: immune control of a moving target
Matti Sallberg et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Selection Pressure From Neutralizing Antibodies Drives Sequence Evolution During Acute Infection With Hepatitis C Virus
Kimberly A. Dowd et al.
GASTROENTEROLOGY (2009)
Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines
K. Witte et al.
GENES AND IMMUNITY (2009)
Diagnosis, Management, and Treatment of Hepatitis C: An Update
Marc G. Ghany et al.
HEPATOLOGY (2009)
Priming of CD4+ and CD8+ T cell responses using a HCV core ISCOMATRIX™ vaccine A phase I study in healthy volunteers
Debbie Drane et al.
HUMAN VACCINES (2009)
Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users
M. Zeremski et al.
JOURNAL OF VIRAL HEPATITIS (2009)
Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial
L. Alvarez-Lajonchere et al.
JOURNAL OF VIRAL HEPATITIS (2009)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Vijayaprakash Suppiah et al.
NATURE GENETICS (2009)
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka et al.
NATURE GENETICS (2009)
Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C
Heiner Wedemeyer et al.
VACCINE (2009)
T-cell vaccines that elicit effective immune responses against HCV in chimpanzees may create greater immune pressure for viral mutation
I. Zubkova et al.
VACCINE (2009)
Genetic factors in mother-to-child transmission of HCV infection
Elena Bevilacqua et al.
VIROLOGY (2009)
Therapeutic vaccination of chronic hepatitis c nonresponder patients with the peptide vaccine IC41
Christoph S. Klade et al.
GASTROENTEROLOGY (2008)
Neutralizing Host Responses in Hepatitis C Virus Infection Target Viral Entry at Postbinding Steps and Membrane Fusion
Anita Haberstroh et al.
GASTROENTEROLOGY (2008)
Selection of high-avidity CD8 T cells correlates with control of hepatitis C virus infection
Berangere Neveu et al.
HEPATOLOGY (2008)
Chimeric GB virus B genomes containing hepatitis C virus p7 are infectious in vivo
Stephen Griffin et al.
JOURNAL OF HEPATOLOGY (2008)
Cutting edge: Programmed death-1 expression is increased on immunocytes in chronic hepatitis C virus and predicts failure of response to antiviral therapy: Race-dependent differences
Lucy Golden-Mason et al.
JOURNAL OF IMMUNOLOGY (2008)
High-Programmed Death-1 Levels on Hepatitis C Virus-Specific T Cells during Acute Infection Are Associated with Viral Persistence and Require Preservation of Cognate Antigen during Chronic Infection
Alleluiah Rutebemberwa et al.
JOURNAL OF IMMUNOLOGY (2008)
Hepatitis C virus (HCV)-specific immune responses of long-term injection drug users frequently exposed to HCV
Eishiro Mizukoshi et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Hepatitis C Virus (HCV)-Specific T Cell Responses in Injection Drug Users with Apparent Resistance to HCV Infection
Prem H. Thurairajah et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Previously infected chimpanzees are not consistently protected against reinfection or persistent infection after reexposure to the identical hepatitis C virus strain
Jens Bukh et al.
JOURNAL OF VIROLOGY (2008)
Evidence for Protection against Chronic Hepatitis C Virus Infection in Chimpanzees by Immunization with Replicating Recombinant Vaccinia Virus
Jin-Won Youn et al.
JOURNAL OF VIROLOGY (2008)
Increased cytotoxic T-lymphocyte epitope variant cross-recognition and functional avidity are associated with hepatitis C virus clearance
Daniel Yerly et al.
JOURNAL OF VIROLOGY (2008)
Hepatic Transcriptome Analysis of Hepatitis C Virus Infection in Chimpanzees Defines Unique Gene Expression Patterns Associated with Viral Clearance
Santosh Nanda et al.
PLOS ONE (2008)
Stable cytotoxic T cell escape mutation in hepatitis C virus is linked to maintenance of viral fitness
Luke Uebelhoer et al.
PLOS PATHOGENS (2008)
High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome
Victoria Kasprowicz et al.
JOURNAL OF VIROLOGY (2008)
Evidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infection
Peter Hraber et al.
HEPATOLOGY (2007)
Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus (HCV) 1b who failed to respond to interferon-based therapy
Shigeru Yutani et al.
VACCINE (2007)
Molecular signature of CD8+ T cell exhaustion during chronic viral infection
E. John Wherry et al.
IMMUNITY (2007)
Functional and phenotypic characterization of peptide-vaccine-induced HCV-specific CD8+T cells in healthy individuals and chronic hepatitis C patients
Verena Schlaphoff et al.
VACCINE (2007)
Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice
Hisaya Azuma et al.
NATURE BIOTECHNOLOGY (2007)
Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma
Pei Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees
Gamal A. Elmowalid et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C
Jan M. Pestka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity
Christine S. Rollier et al.
HEPATOLOGY (2007)
Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCVNS3 and Core proteins
Aurelia A. Haller et al.
VACCINE (2007)
Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo
Thomas Von Hahn et al.
GASTROENTEROLOGY (2007)
Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C
David E. Kaplan et al.
GASTROENTEROLOGY (2007)
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection
Martin Lagging et al.
HEPATOLOGY (2006)
Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-α and plasmacytoid dendritic cell loss in chronic HCV infection
Angela Dolganiuc et al.
JOURNAL OF IMMUNOLOGY (2006)
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
Joseph F. Perz et al.
JOURNAL OF HEPATOLOGY (2006)
CD4+ immune escape and subsequent T-cell failure following chimpanzee immunization against hepatitis C virus
Montserrat Puig et al.
HEPATOLOGY (2006)
Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: A randomized, placebo controlled trial for dose optimization in 128 healthy subjects
Christa Firbas et al.
VACCINE (2006)
Hierarchy of baby-linked immunogenetic risk factors in the vertical transmission of hepatitis C virus
M. Martinetti et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2006)
A target on the move: Innate and adaptive immune escape strategies of hepatitis C virus
R Thimme et al.
ANTIVIRAL RESEARCH (2006)
A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees
A Folgori et al.
NATURE MEDICINE (2006)
Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies
JM Micallef et al.
JOURNAL OF VIRAL HEPATITIS (2006)
Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee
JW Youn et al.
HEPATOLOGY (2005)
Assembly of functional hepatitis C virus glycoproteins on infectious pseudoparticles occurs intracellularly and requires concomitant incorporation of E1 and E2 glycoproteins
V Sandrin et al.
JOURNAL OF GENERAL VIROLOGY (2005)
Protection against chronic hepatitis C virus infection after rechallenge with homologous, but not heterologous, genotypes in a chimpanzee model
AM Prince et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Adaptive immune responses in acute and chronic hepatitis C virus infection
DG Bowen et al.
NATURE (2005)
Characterization of liver histopathology in a transgenic mouse model expressing genotype 1a hepatitis C virus core and envelope proteins 1 and 2
T Naas et al.
JOURNAL OF GENERAL VIROLOGY (2005)
Comprehensive analyses of CD8+T cell responses during longitudinal study of acute human hepatitis C
AL Cox et al.
HEPATOLOGY (2005)
Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection
D Lavillette et al.
JOURNAL OF VIROLOGY (2005)
Effect of IL-4 and IL-13 on collagen production in cultured LI90 human hepatic stellate cells
R Sugimoto et al.
LIVER INTERNATIONAL (2005)
Inhibition of hepatitis c virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C
D Steinmann et al.
JOURNAL OF VIROLOGY (2004)
Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease
AM Wertheimer et al.
HEPATOLOGY (2004)
Isolation and functional analysis of circulating dendritic cells from hepatitis C virus (HCV) RNA-positive and HCV RNA-negative patients with chronic hepatitis C: role of antiviral therapy
E Tsubouchi et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Neutralizing antibody response during acute and chronic hepatitis C virus infection
C Logvinoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source
SM McKiernan et al.
HEPATOLOGY (2004)
Cellular immune responses in seronegative sexual contacts of acute hepatitis C patients
SM Kamal et al.
JOURNAL OF VIROLOGY (2004)
Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: A population-based study
JA Davila et al.
GASTROENTEROLOGY (2004)
Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort
JJ Post et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
HCV persistence and immune evasion in the absence of memory T cell help
A Grakoui et al.
SCIENCE (2003)
Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation
CE Harvey et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection
NH Shoukry et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis C
F Nevens et al.
HEPATOLOGY (2003)
Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease
R Thimme et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus
H Lerat et al.
GASTROENTEROLOGY (2002)
Frequencies of HCV-specific effector CD4+T cells by flow cytometry: Correlation with clinical disease stages
HR Rosen et al.
HEPATOLOGY (2002)
Immune responses and immunity in hepatitis C virus infection
E Mizukoshi et al.
JOURNAL OF GASTROENTEROLOGY (2001)
Hepatitis C virus replication in mice with chimeric human livers
DF Mercer et al.
NATURE MEDICINE (2001)
Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection
KM Chang et al.
HEPATOLOGY (2001)
Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C
TF Baumert et al.
HEPATOLOGY (2000)
The natural history of hepatitis C virus infection - Host, viral, and environmental factors
DL Thomas et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C
A Takaki et al.
NATURE MEDICINE (2000)
Share Paper
